| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Scandion Oncology A/S (ST: SCOL)
SCOL Technical Analysis
5
| As on 22nd Nov 2024 SCOL STOCK Price closed @ 0.07 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 2.07 & Strong Sell for SHORT-TERM with Stoploss of 1.66 we also expect STOCK to react on Following IMPORTANT LEVELS. |
SCOLSTOCK Price
| Open | 0.07 | Change | Price | % |
| High | 0.07 | 1 Day | -0.01 | -12.50 |
| Low | 0.07 | 1 Week | 0.00 | 0.00 |
| Close | 0.07 | 1 Month | -0.06 | -46.15 |
| Volume | 605912 | 1 Year | -1.32 | -94.96 |
| 52 Week High 4.90 | 52 Week Low 0.07 | ||||
ST Sweden Most Active Stocks
| TANGI | 0.00 | % |
| FING-B | 0.08 | 0.00% |
| SBB-B | 4.00 | 1.78% |
| LUNE | 21.97 | 6.65% |
| SNM | 0.88 | 2.33% |
| DIABIO | 0.03 | 0.00% |
| WYLD | 0.02 | 0.00% |
| NIBE-B | 45.75 | 1.87% |
| HDW-B | 0.00 | % |
| EURA | 0.01 | 0.00% |
ST Sweden Top Gainers Stocks
ST Sweden Top Losers Stocks
| SCOL Daily Charts |
SCOL Intraday Charts |
Whats New @ Bazaartrend |
SCOL Free Analysis |
|
|
SCOL Important Levels Intraday
| RESISTANCE | 0.07 |
| RESISTANCE | 0.07 |
| RESISTANCE | 0.07 |
| RESISTANCE | 0.07 |
| RESISTANCE | 0.07 |
| RESISTANCE | 0.07 |
| RESISTANCE | 0.07 |
| RESISTANCE | 0.07 |
SCOL Forecast November 2024
| 4th UP Forecast | 1.19 |
| 3rd UP Forecast | 0.83 |
| 2nd UP Forecast | 0.61 |
| 1st UP Forecast | 0.39 |
| 1st DOWN Forecast | -0.25 |
| 2nd DOWN Forecast | -0.47 |
| 3rd DOWN Forecast | -0.69 |
| 4th DOWN Forecast | -1.05 |
SCOL Weekly Forecast
| 4th UP Forecast | 0.61 |
| 3rd UP Forecast | 0.44 |
| 2nd UP Forecast | 0.33 |
| 1st UP Forecast | 0.22 |
| 1st DOWN Forecast | -0.08 |
| 2nd DOWN Forecast | -0.19 |
| 3rd DOWN Forecast | -0.30 |
| 4th DOWN Forecast | -0.47 |
SCOL Forecast2024
| 4th UP Forecast | 10.82 |
| 3rd UP Forecast | 7.37 |
| 2nd UP Forecast | 5.24 |
| 1st UP Forecast | 3.11 |
| 1st DOWN Forecast | -2.97 |
| 2nd DOWN Forecast | -5.1 |
| 3rd DOWN Forecast | -7.23 |
| 4th DOWN Forecast | -10.68 |
Scandion Oncology A/S ( ST Sweden Symbol : SCOL )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
SCOL Business Profile
Scandion Oncology A/S, a biotechnology company, develops drugs for the treatment of chemotherapy resistance in cancer patients. Its products under development include SCO-101, which is in Phase II clinical trial for use in the treatment of breast and colorectal cancers; and SCO-201, a late pre-clinical stage product for use in the treatment of solid tumors. Scandion Oncology A/S has a collaboration agreement with Alligator Bioscience AB to explore combination therapies for chemotherapy and immunooncology. The company was founded in 2017 and is based in Copenhagen, Denmark. Address: Symbion, Copenhagen, Denmark, 2100
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service